256 related articles for article (PubMed ID: 20087842)
21. Semiparametric models for missing covariate and response data in regression models.
Chen Q; Ibrahim JG
Biometrics; 2006 Mar; 62(1):177-84. PubMed ID: 16542244
[TBL] [Abstract][Full Text] [Related]
22. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
O'Rourke K; Altman DG
Stat Med; 2005 Sep; 24(17):2733-42; author reply 2743. PubMed ID: 16118810
[TBL] [Abstract][Full Text] [Related]
23. Bayesian random-effects threshold regression with application to survival data with nonproportional hazards.
Pennell ML; Whitmore GA; Ting Lee ML
Biostatistics; 2010 Jan; 11(1):111-26. PubMed ID: 19828558
[TBL] [Abstract][Full Text] [Related]
24. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of repeated measures study designs.
Peters JL; Mengersen KL
J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
[TBL] [Abstract][Full Text] [Related]
26. An extended general location model for causal inferences from data subject to noncompliance and missing values.
Peng Y; Little RJ; Raghunathan TE
Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
[TBL] [Abstract][Full Text] [Related]
27. Multilevel modelling of medical data.
Goldstein H; Browne W; Rasbash J
Stat Med; 2002 Nov; 21(21):3291-315. PubMed ID: 12375305
[TBL] [Abstract][Full Text] [Related]
28. A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity.
Kuhnert R; Böhning D
Stat Med; 2007 May; 26(11):2277-96. PubMed ID: 16991109
[TBL] [Abstract][Full Text] [Related]
29. Multiplicative interaction in network meta-analysis.
Piepho HP; Madden LV; Williams ER
Stat Med; 2015 Feb; 34(4):582-94. PubMed ID: 25410043
[TBL] [Abstract][Full Text] [Related]
30. A Bayesian approach to a logistic regression model with incomplete information.
Choi T; Schervish MJ; Schmitt KA; Small MJ
Biometrics; 2008 Jun; 64(2):424-30. PubMed ID: 17764482
[TBL] [Abstract][Full Text] [Related]
31. Partly conditional survival models for longitudinal data.
Zheng Y; Heagerty PJ
Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
[TBL] [Abstract][Full Text] [Related]
32. The impact of missing data in a generalized integer-valued autoregression model for count data.
Alosh M
J Biopharm Stat; 2009 Nov; 19(6):1039-54. PubMed ID: 20183463
[TBL] [Abstract][Full Text] [Related]
33. Modelling risk when binary outcomes are subject to error.
McInturff P; Johnson WO; Cowling D; Gardner IA
Stat Med; 2004 Apr; 23(7):1095-109. PubMed ID: 15057880
[TBL] [Abstract][Full Text] [Related]
34. Bayesian analysis of latent variable models with non-ignorable missing outcomes from exponential family.
Song XY; Lee SY
Stat Med; 2007 Feb; 26(3):681-93. PubMed ID: 16538704
[TBL] [Abstract][Full Text] [Related]
35. A Bayesian approach to meta-analysis of plant pathology studies.
Mila AL; Ngugi HK
Phytopathology; 2011 Jan; 101(1):42-51. PubMed ID: 20822433
[TBL] [Abstract][Full Text] [Related]
36. Likelihood methods for regression models with expensive variables missing by design.
Zhao Y; Lawless JF; McLeish DL
Biom J; 2009 Feb; 51(1):123-36. PubMed ID: 19197954
[TBL] [Abstract][Full Text] [Related]
37. Bayesian bivariate meta-analysis of diagnostic test studies using integrated nested Laplace approximations.
Paul M; Riebler A; Bachmann LM; Rue H; Held L
Stat Med; 2010 May; 29(12):1325-39. PubMed ID: 20101670
[TBL] [Abstract][Full Text] [Related]
38. Power analyses for longitudinal study designs with missing data.
Tu XM; Zhang J; Kowalski J; Shults J; Feng C; Sun W; Tang W
Stat Med; 2007 Jul; 26(15):2958-81. PubMed ID: 17154250
[TBL] [Abstract][Full Text] [Related]
39. Structured additive regression for categorical space-time data: a mixed model approach.
Kneib T; Fahrmeir L
Biometrics; 2006 Mar; 62(1):109-18. PubMed ID: 16542236
[TBL] [Abstract][Full Text] [Related]
40. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
Renfro LA; Shi Q; Sargent DJ; Carlin BP
Stat Med; 2012 Apr; 31(8):743-61. PubMed ID: 22161275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
